CAMK2A and glioblastoma: Immunostaining and single cell based image quantitation of the proportion of CaMK2A phosphorylation in treated vs. untreated cells in glioblastoma cells and normal cells clearly suggested significant increase in phospho-CaMK2A in all glioblastoma cell lines vs. their untreated controls (Figures 9A,B).